For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Québec, Quebec G1W 4R4

0 studies enrolling now · 8 studies all time

What they study most

Alzheimer's Disease, Attention Deficit Hyperactivity Disorder, Cardiovascular Disease, Diabetes Mellitus, Type 2, Ejaculatory Dysfunction, Hypogonadism, Osteoporosis, Postmenopausal, Psoriasis, Rheumatoid Arthritis, Spondylitis, Ankylosing

Studies at this site

• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) — Completed
• A Study in Moderate to Severe Rheumatoid Arthritis Participants — Completed
• Effect of LY450139 on the Long Term Progression of Alzheimer's Disease — Completed
• A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels — Completed
• Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) — Withdrawn before enrolling
• A Study for Adults With Plaque Psoriasis — Stopped early
• Long-Term, Open Label Atomoxetine Study — Completed
• Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis — Completed